Top Markets
#1 CoW Protocol CoW Protocol +59.38%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +39.17%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.40%
#6 Humanity Humanity +22.30%
#7 Enso Enso +17.07%
#8 Velvet Velvet +17.00%
#9 Tutorial Tutorial +16.94%
#10 Huma Finance Huma Finance +14.02%
Coin of the day
CoW Protocol CoW Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Kedudukan dalam Saham #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Harga Saham
$0.6
Disegerakkan terakhir: 2024-08-14
Modal Pasaran
$2.09M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
SG
Perdagangan ASLAN Pharmaceuticals Limited (ASLN)

Kategori

Healthcare
EPS untuk ASLAN Pharmaceuticals Limited (ASLN)
EPS setakat March 2024 TTM: $-7.92
Menurut laporan kewangan terkini dan harga saham ASLAN Pharmaceuticals Limited, EPS semasa syarikat (TTM) adalah $-7.92. Pada akhir tahun 2022, syarikat mempunyai EPS sebanyak $-14.72 peningkatan berbanding EPS tahun 2021 iaitu $-10.64.
Sejarah EPS untuk ASLAN Pharmaceuticals Limited dari 2014 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-7.92 -26.39%
2023 $-10.76 -26.90%
2022 $-14.72 38.35%
2021 $-10.64 14.16%
2020 $-9.32 -67.86%
2019 $-29.00 2.98%
2018 $-28.16 -13.94%
2017 $-32.72 372.83%
2016 $-6.92 -71.40%
2015 $-24.20 -79.00%
2014 $-115.24 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -318.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -450.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -272.98%
BE